Jefferies Financial Group Inc. Amgen Inc Put Options Transaction History

Jefferies Financial Group Inc.

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $118 Million - $128 Million	380,300 Added 1855.12%	400,800 $129 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $2.63 Million - $3.19 Million	10,000 Added 95.24%	20,500 $6.41 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $2.69 Million - $3.25 Million	10,000 Added 2000.0%	10,500 $2.99 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $546,625 - $678,650	-2,500 Reduced 83.33%	500 $134,000
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $14.7 Million - $17.4 Million	-68,700 Reduced 95.82%	3,000 $666,000
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $22.2 Million - $27.1 Million	-98,500 Reduced 57.87%	71,700 $17.3 Million
Q4 2022 Sep 21, 2023	BUY	$229.03 - $291.01 $38.3 Million - $48.7 Million	167,200 Added 5573.33%	170,200 $44.7 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $39 Million - $49.5 Million	170,200 New	170,200 $44.7 Million

3,122

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.